Novartis Investigative Site

Giengen an der Brenz 89537

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Heart Failure With Reduced Ejection Fraction, Hypertension

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Efficacy and Safety of LCZ696A in Patients With Essential Hypertension — Completed